- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · research · R01
Polyploidy, aneuploidy, and genome stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2020 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center Project HOPE: The Pediatric/AYA Omics Project
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2024 · research · R01
Polyploidy, Aneuploidy and Genome Stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Dana-Farber/Harvard Cancer Center
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Dana-Farber/Harvard Cancer Center
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
NCI Early Career Cancer Clinical Investigator Award
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 02: Gynecologic Cancers
Ursula Anne Matulonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 6: Lymphoma and Myeloma
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Administrative Core
Deborah J Goff · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Cancer Research and Training Coordination
Lee Marshall Nadler · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Sample Processing and Analysis
James Douglas Griffin · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 04 Leukemia
David Marc Weinstock · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Sample Processing and Banking
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Biostatistics Core
Donna S. Neuberg · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Health Communication Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 10: Specialized Histopathology
Jon C. Aster · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Early Phase Clinical Research Support
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Leadership, Planning, and Evaluation
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 11: Cancer Immunology
Arlene H. Sharpe · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Specialized Histopathology Core
Jon C. Aster · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Sample Processing and Analysis
James Douglas Griffin · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Biology and therapeutic targeting of zinc finger transcription factors in AML
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Administrative Core
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 60: Cancer Risk, Prevention, and Early Detection
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Shared Resource Management
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 12: Genotyping and Genetics for Population Sciences
Immaculata De Vivo · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Clinical Research Support
Richard M Stone · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Clinical Protocol and Data Management
Jeffrey A Meyerhardt · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 34: Lung Cancer
Bruce E. Johnson · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 09 Cancer Genetics
David J. Kwiatkowski · Dana-Farber Cancer Institute · funded by National Institutes of Health
